Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› IL23p19
IL23p19
(1 companies · 2 programs)
Companies with an active program directed at IL23p19.
Xencor Inc
XNCR
XmAb412
— Crohn's Disease
Preclinical
XmAb412
— Ulcerative Colitis
Preclinical